Publications by authors named "Satish S Modi"

Claim this Profile
C
Comparison of visual function and patient-reported outcomes between two full range of field intraocular lenses: a randomized controlled study.
Satish S Modi, Robert P Lehmann, Bret L Fisher, Richard E Roth, Harvey Reiser

J Cataract Refract Surg· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rotational Stability of the Clareon Monofocal Aspheric Hydrophobic Acrylic Intraocular Lens 6 Months After Implantation.
Thomas R Walters, Robert Lehmann, Andrew Moyes, John W French, Vidhyapriya Sreenivasan, Satish S Modi

Clin Ophthalmol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes after aphakic versus aphakic/pseudophakic intraoperative aberrometry in cataract surgery with toric IOL implantation.
Satish S Modi

Int Ophthalmol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Once-daily nepafenac ophthalmic suspension 0.3% to prevent and treat ocular inflammation and pain after cataract surgery: phase 3 study.
Satish S Modi, Robert P Lehmann, Thomas R Walters, Raymond Fong, William C Christie

J Cataract Refract Surg· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, efficacy, and intraoperative characteristics of DisCoVisc and Healon ophthalmic viscosurgical devices for cataract surgery.
Satish S Modi, James A Davison, Tom Walters

Clin Ophthalmol· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional outcomes after bilateral implantation of apodized diffractive aspheric acrylic intraocular lenses with a +3.0 or +4.0 diopter addition power Randomized multicenter clinical study.
W Andrew Maxwell, Robert J Cionni, Robert P Lehmann, Satish S Modi

J Cataract Refract Surg· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nepafenac ophthalmic suspension 0.1% for the prevention and treatment of ocular inflammation associated with cataract surgery.
Stephen S Lane, Satish S Modi, Robert P Lehmann, Edward J Holland

J Cataract Refract Surg· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis